Belgrade

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Melanoma1 trial
• Multiple sclerosis1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Sandoz2 trials

Running trials

• Active, not recruiting

  Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple Sclerosis

  NCT06847724· Phase 3· Sandoz· Source

Closed trials

• Completed

  A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma

  NCT06153238· Phase 1· Sandoz· Source